Jiale Lin
4 Papers
Jiale Lin is an academic researcher. The author has contributed to research in topics: Cancer & Internal medicine. The author has co-authored 2 publications.
Chat about Author
Papers
Development and validation of LightGBM algorithm for optimizing of Helicobacter pylori antibody during the minimum living guarantee crowd based gastric cancer screening program in Taizhou, China.
Xinxin Fu,Xin-Li Mao,Jiale Lin,Zongfang Ma,Zhi Cheng Liu,Yue Cai,Ling-ling Yan,Li-Ping Ye,Shao-wei Li +8 more
TL;DR: Wang et al. as mentioned in this paper used light gradient boosting machine (lightGBM) algorithm to develop a predictive model for gastric cancer risk and found that H. pylori IgG appears to be able to be excluded from the prediction model without significantly affecting its performance, which is important from a health economic point of view.
5
New hope for esophageal stricture prevention: A prospective single-center trial on acellular dermal matrix
Xinxin Fu,Zhen-Yu Jiang,Chen-Yang Zhang,Ling-Yan Shen,Xiao-Dan Yan,Xiao-Kang Li,Jiale Lin,Yi Wang,Xin-Li Mao,Shao-wei Li +9 more
TL;DR: It is hypothesized that acellular dermal matrix (ADM) may be similarly effective to autologous mucosal transplantation in the prevention of esophageal stricture, offering a comparable and alternative approach.
1
Development and Validation of a Machine Learning Algorithm for the Detection of Helicobacter Pylori Antibody During the Minimum Living Guarantee Crowd Based Gastric Cancer Screening Program in Taizhou, China
Xinxin Fu,Xinli Mao,Hao Wu,Jiale Lin,Zongfang Ma,Zhi-Cheng Liu,Yue Cai,Ling-ling Yan,Yi Sun,Liping Ye,Shao-wei Li +10 more
Developing a Prognostic Model for Primary Biliary Cholangitis Based on a Random Survival Forest Model
Xinxin Fu,Ya-Qi Song,Jiale Lin,Yi Wang,Wei-dan Wu,Jin-bang Peng,Li-ping Ye,Kai Chen,Shao-wei Li +8 more
TL;DR: A prognostic model for PBC-associated cirrhosis patients is constructed using a random survival forest model, which accurately stratified patients into low- and high-risk groups, leading to improved outcomes for high-risk patients.